Add your Insight
15 February 2021
Image guided therapies for treatment of colorectal cancer metastases
We are pleased to announce a new developing Special Issue for the International Journal of Hyperthermia and Thermal Therapies. This Special Issue will focus on use of image guided therapies for treatment of colorectal cancer metastases. A very prestigious list of key authors have agreed to participate. We invite you to submit a paper on the broad subject of "Image guided therapies for treatment of colorectal cancer metastases", for potential inclusion within the Special Issue, pending successful peer review.
Listed below are the invited authors and manuscript titles that will be included.
- Matthew Callstrom: Mayo Clinic, “Ablation for Oligometastatic CRC disease in non-hepatic/non-pulmonary sites”
- Thierry DeBaere: Institute Gustave Roussy, “Ablation in Hepatic and Pulmonary oligometastatic disease”
- Bruno Odisio and Constantinos Sofocleous: MD Anderson Cancer Center & Memorial Sloan Kettering Cancer Center, “Liver metatastases: Rationale, indications and outcomes of thermal ablation as a local curative therapy: When should it be used instead of resection”.
- Raj Narayanan: Baptists Health - Miami Cardiac and Vascular Institute, “IRE for CRC Liver Metastases: Indications and Outcomes”
- Robert Lewandowski: Northwestern University, “Y90 radiation segmentectomy in CRC metastatic disease: Rationale, Indications and Outcomes”
- Ali Hosni Abdalaty and Laura Dawson: Princess Margaret Cancer Center, “IMRT/SBRT/Proton therapy: Indications and evidence for treatment of CRC metastases”
- Juan Camacho, Stephen B. Solomon: Memorial Sloan Kettering Cancer Center, "Pulmonary Metastases: Rationale, Indications and Outcomes of thermal ablation”
- Stephen Hunt: University of Pennsylvania, “Molecular Imaging, a valuable tool in Management of Colorectal Metastatic Disease by Interventional Oncology”.
Looking to Publish your Research?
We aim to make publishing with Taylor & Francis a rewarding experience for all our authors. Please visit our Author Services website for more information and guidance, and do contact us if there is anything we can help with!
- Both reviews and original research manuscripts will be considered for inclusion in this Special Issue. Papers can focus on:
- Clinical studies/trials (case reports are excluded)
- Physics and Engineering of relevant devices
- Biomarkers of treatment response/survival, with emphasis on imaging biomarkers
- Biology of CRC metastases as pertaining to image guided therapy
- Expected publication date- Late summer/early fall, 2021
- When submitting your manuscript, please include a cover letter explaining why you believe that your paper should be included in the Special Issue
- Select "special issue title" when submitting your manuscript to the Scholar One site
- Manuscript length - Maximum of 5000 words
- Figures / Tables - Maximum of 6. Figures can contain multiple panels.
View the latest tweets from tandfmedicine